← Back to Search

Behavioral Intervention

The PATTERN Intervention for Medication Adherence

N/A
Recruiting
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be primarily responsible for administering own medication
Have a diagnosis of at least diabetes, hypertension, and hyperlipidemia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up by the scheduled clinic visit (baseline)
Awards & highlights

Study Summary

This trial is testing a new method for regularly checking how well older adults with multiple chronic conditions are taking their medications. The goal is to see if this new technology can help improve medication use and adherence.

Who is the study for?
This trial is for English-speaking adults aged 65 or older with diabetes, hypertension, and hyperlipidemia who take 8+ medications. Participants must manage their own meds, have internet access, an email address, and use the patient portal MyChart at a specific primary care practice.Check my eligibility
What is being tested?
The PATTERN Intervention is being tested to see if it can help monitor medication use in older adults with multiple chronic conditions using technology. The study aims to adapt this strategy for routine checks on how well patients stick to their prescribed drug regimens.See study design
What are the potential side effects?
Since this trial focuses on monitoring medication adherence through technology rather than testing new drugs, there are no direct side effects from interventions like those found in pharmaceutical trials.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I manage my own medication.
Select...
I have been diagnosed with diabetes, high blood pressure, and high cholesterol.
Select...
I am 65 years old or older.
Select...
I am currently taking 8 or more medications.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~about 2-4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and about 2-4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Medication Adherence
Secondary outcome measures
Fidelity

Trial Design

2Treatment groups
Active Control
Group I: The PATTERN InterventionActive Control1 Intervention
The intervention components include: An adherence assessment completed by participants ahead of a regularly scheduled clinic visit. Care alert notifications directed to a nurse pool and/or member of the clinical care team.
Group II: Usual CareActive Control1 Intervention
Usual care includes: The normal standard clinical practices at the participating practice. No specific materials to promote PATTERN, and no additional materials that include adherence assessments or care alert notifications.

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,675 Previous Clinical Trials
28,020,805 Total Patients Enrolled
Northwestern UniversityLead Sponsor
1,589 Previous Clinical Trials
917,007 Total Patients Enrolled
The Claude D. Pepper Older Americans Independence CentersOTHER
9 Previous Clinical Trials
218 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available positions for patients to participate in this clinical trial?

"Indeed, according to the details provided on clinicaltrials.gov, this trial is currently seeking patients. The study was initially posted on January 11th, 2024 and last updated on January 18th, 2024. It aims to enroll a total of 80 participants at a single site."

Answered by AI

What is the current number of individuals undergoing treatment in this medical study?

"Indeed, according to the details available on clinicaltrials.gov, this research study is actively seeking eligible candidates. The trial was initially posted on January 11th, 2024 and was most recently updated on January 18th, 2024. A total of 80 patients will be enrolled in the trial at a single site."

Answered by AI
~50 spots leftby Sep 2024